Published in Br J Cancer on September 16, 2014
Cytokine-Induced Modulation of Colorectal Cancer. Front Oncol (2016) 0.84
Longitudinal Study of DNA Methylation of Inflammatory Genes and Cancer Risk. Cancer Epidemiol Biomarkers Prev (2015) 0.78
Retracted Quantitative DNA hypomethylation of ligand Jagged1 and receptor Notch1 signifies occurrence and progression of breast carcinoma. Am J Cancer Res (2015) 0.77
Quantitative DNA hypomethylation of ligand Jagged1 and receptor Notch1 signifies occurrence and progression of breast carcinoma. Am J Cancer Res (2015) 0.76
Exercise-conditioned plasma attenuates nuclear concentrations of DNA methyltransferase 3B in human peripheral blood mononuclear cells. Physiol Rep (2015) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 40.32
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 38.57
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A (2005) 10.89
Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol (2006) 9.42
Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol (2008) 6.01
DNA methylation controls Foxp3 gene expression. Eur J Immunol (2008) 4.19
Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res (1974) 3.96
Tregs and rethinking cancer immunotherapy. J Clin Invest (2007) 3.77
Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res (2003) 3.44
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res (2006) 3.38
TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev (2006) 3.14
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol (2007) 2.92
FOXP3 expression and overall survival in breast cancer. J Clin Oncol (2009) 2.71
The clinical significance of invasion of veins by rectal cancer. Br J Surg (1980) 2.69
Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res (2009) 2.62
Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol (2004) 2.62
FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res (2007) 2.21
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res (2007) 2.21
T cells and aging, January 2002 update. Front Biosci (2002) 2.14
From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol (1994) 2.09
Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut (2002) 1.81
Reporting colorectal cancer. Histopathology (2007) 1.68
CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS One (2006) 1.68
Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med (1991) 1.66
The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res (2008) 1.64
Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res (2002) 1.54
Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg (2004) 1.49
Epigenetic regulation of tumor necrosis factor alpha. Mol Cell Biol (2007) 1.46
Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun (2007) 1.43
Population-based study of prognostic factors in stage II colonic cancer. Br J Surg (2006) 1.16
Intra-tumoural regulatory T cells: a potential new target in cancer immunotherapy. Biochem Biophys Res Commun (2006) 1.16
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer. J Transl Med (2006) 1.15
Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer. PLoS One (2013) 1.13
Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection. Br J Cancer (2000) 1.08
Antitumoral activity of interferon-gamma involved in impaired immune function in cancer patients. Curr Drug Metab (2006) 0.99
TNFα enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl- and sulfotransferase genes involved in the synthesis of selectin ligands. Biochem Biophys Res Commun (2011) 0.98
Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer. J Clin Gastroenterol (2002) 0.96
Retracted Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome. J Interferon Cytokine Res (2002) 0.96
Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients. Anticancer Res (2005) 0.95
Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res (1998) 0.95
The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival. Br J Cancer (2006) 0.91
Objective criteria for the grading of venous invasion in colorectal cancer. Am J Surg Pathol (2010) 0.91
Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data. Dis Esophagus (2009) 0.90
Characterization of intracellular cytokine profile of CD4(+) T cells in peripheral blood and tumor-draining lymph nodes of patients with gastrointestinal cancer. Jpn J Clin Oncol (2000) 0.85
Cytocidal mechanism of TNF: effects of lysosomal enzyme and hydroxyl radical inhibitors on cytotoxicity. Immunopharmacol Immunotoxicol (1988) 0.83
The effect of colorectal cancer upon host peripheral immune cell function. Colorectal Dis (2009) 0.79
Leptin and the immunosuppression of malnutrition. J Clin Endocrinol Metab (2002) 0.78